- Home
- VRA vs ALGS Comparison
VRA vs ALGS Comparison
Compare VRA & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRA | ALGS |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 57.2M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VRA | ALGS |
|---|---|---|
| Price | $1.95 | $13.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.00 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 2.3M | 81.5K |
| Earning Date | 12-11-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $324,296,000.00 | $2,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.39 | $3.76 |
| 52 Week High | $4.73 | $46.80 |
Technical Indicators
Market Signals| Indicator | VRA | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 80.94 |
| Support Level | $1.39 | $9.10 |
| Resistance Level | $2.26 | $10.45 |
| Average True Range (ATR) | 0.21 | 0.75 |
| MACD | -0.09 | 0.38 |
| Stochastic Oscillator | 35.04 | 92.29 |
Price Performance
Historical ComparisonAbout VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.